ReviewNanomedicine (London, England)2018

Nucleic acid nanomedicines in Phase II/III clinical trials: translation of nucleic acid therapies for reprogramming cells.

Victoria Lm Herrera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.